5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract

Digestive and Liver Disease

Volumn 35, Issue 4, 2003, Pages 244-250

  Tonini, Marcello ^a   De Giorgio, R ^b   Spelta, V ^a   Bassotti, G ^c   Di Nucci, A ^a   Anselmi, L ^a   Balestra, B ^a   De Ponti, F ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

5 HT4 receptors; Guinea pig gastrointestinal tract; Levosulpiride

Indexed keywords

2 METHYLSEROTONIN; 5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; BENZAMIDE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MOSAPRIDE CITRATE; MUSCARINIC RECEPTOR BLOCKING AGENT; NEPADUTANT; NOLPITANTIUM; PHYSOSTIGMINE; SCOPOLAMINE; SEROTONIN 3 AGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SULPIRIDE; TACHYKININ RECEPTOR ANTAGONIST; TETRODOTOXIN; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFONAMIDE;

ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DYSPEPSIA; GASTROINTESTINAL MOTILITY; GUINEA PIG; MALE; NONHUMAN; SEROTONINERGIC SYSTEM; STOMACH MUSCLE; ANIMAL; COLON; DRUG EFFECT; ELECTROSTIMULATION; IN VITRO STUDY; MUSCLE CONTRACTION; MYENTERIC PLEXUS; PHYSIOLOGY; SMOOTH MUSCLE; STOMACH ANTRUM;

ANIMALS; COLON; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; GUINEA PIGS; INDOLES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; PYLORIC ANTRUM; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES; SULPIRIDE;

EID: 0041807628     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00061-6     Document Type: Article

References (40)

1. Corazza GR, Biagi F, Albano O. Levosulpiride in functional dispepsia: A multicentric, double-blind, controlled trial. Ital J Gasto troenterol 1996;28:317-23.
2. Corazza GR, Tonini M. Levosulpiride for dispepsia and emesis. A review of its pharmacology, efficacy and tolerability. Clin Drug Invest 2000;19:151-62.
3. Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N, et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000;14:561-9.
4. Shichijo K, Sakurai-Yamashita Y, Semine I, Taniyama K. Neuronal release of endogenous dopamine from corpus of guinea pig stomach. Am J Physiol 1997;273:G1044-50.
5. Eisenhofer G, Åneman A, Friberg P, Hooper D, Fåndriks L, Lonroth H, et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 1997;82:3864-71.
6. Schuurkes JAJ, Van Nueten JM. Is dopamine an inhibitory modulator of gastrointestinal motility? Scand J Gastroenterol 1981;16:33-6.
7. Willems JL, Buylaert WA, Lefebvre RA, Bogaert MG. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 1985;37:165-216.
8. 3H]acetylcholine release from guinea pig stomach. J Pharmacol Exp Ther 1985;284:713-9.
9. 2 dopamine receptor and alpha-2 adrenoceptor. J Pharmacol Exp Ther 1991;257:806-11.
10. Takahashi T, Kurosawa S, Wiley JW, Owyang C. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pig. Gastroenterology 1991;101:703-10.
11. Tonini M. Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol Res 1996;33:217-26.
12. De Ponti F, Malagelada JR. Functional gut disorders: From motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther 1998;80:49-88.
13. Briejer MR, Akkermans LM, Schuurkes JA. Gastrointestinal prokinetic benzamides: The pharmacology underlying stimulation of motility. Pharmacol Rev 1995;47:631-51.
14. Chemnitius JM, Haselmeyer KH, Gonska BD, Kreuzer H, Zech R. Indirect parasympathomimetic activity of metoclopramide: Reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacol Res 1996;34:65-72.
15. Foxx-Orenstein AE, Kuemmerle JF, Grider JR. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996;111:1281-90.
16. De Ponti F, Tonini M. Irritable bowel syndrome. New agents targeting serotonin receptor subtypes. Drugs 2001;63:317-32.
17. 4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol 1995;115:47-56.
18. 4-like receptors. Br J Pharmacol 1996;117:238-9.
19. Gaddum JH. Series of drug antagonism. Pharmacol Rev 1957;9:211-8.
20. Paton WD, Zar MA. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 1968;194:13-33.
21. 2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach. Neuroscience 1997;80:625-34.
22. 4 receptor antagonist. Br J Pharmacol 1994;113:120P.
23. 4 receptors in the human isolated detrusor muscle: Effects of indole, benzimidazolone and substituted benzamide agonists and antagonists. Br J Pharmacol 1996;118:1965-70.
24. 4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release. J Pharmacol Exp Ther 1996;276:989-95.
25. Tamura T, Sano I, Satoh M, Mizumoto A, Itoh Z. Pharmacological characterization of 5-hydroxytryptamine-induced motor activity (in vitro) in the guinea pig gastric antrum and corpus. Eur J Pharmacol 1996;308:315-24.
26. Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, et al. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 2000;35:575-82.
27. Takeda M, Tsukamoto K, Sakurai-Yamashita Y, Suzuki T, Taniyama K. Facilitation of acetylcholine release by SK-951, a benzofuran derivative, via the 5-hydroxytryptamine4 receptor in guinea pig stomach. Jpn J Pharmacol 2000;82:138-43.
28. 4 receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study. Br J Pharmacol 2001;132:1941-7.
29. Costall B, Naylor RJ, Tan CC. A central site of dopamine agonist action to modify gastric secretion in the rat. Eur J Pharmacol 1985;117:61-9.
30. 3 receptor blockade. Eur J Pharmacol 1990;187:323-9.
31. Gullikson GW, Virina MA, Loeffler RF, Yang DC, Goldstin B,Wang SX, et al. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. J Pharmacol Exp Ther 1993;264:240-8.
32. Rizzi CA, Sagrada A, Schiavone A, Schiantarelli P, Cesana R, Schiavi GB, et al. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedebergs Arch Pharmacol 1994;349:338-45.
33. Hegde SS, Wong AG, Perry MR, Ku P, Moy TM, Loeb M, et al. 5-HT4 receptor mediated stimulation of gastric emptying in rats. Naunyn Schmiedebergs Arch Pharmacol 1995;351:589-95.
34. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994;47:116-52.
35. 4 receptor-mediated contractions. Br J Pharmacol 1993;110:1593-9.
36. 4 receptors in guinea-pig colon and rat oesophagus: Effects of novel agonists and antagonists. Naunyn Schmiedebergs Arch Pharmacol 1996;354:145-56.
37. 4 receptors and cholinergic and tachykinergic neurotransmission in the guinea-pig proximal colon. Eur J Pharmacol 1996;308:173-80.
38. Kojima S, Shimo Y. Investigation into the 5-hydroxytryptamine-induced atropine-resistant neurogenic contraction of guinea-pig proximal colon. Br J Pharmacol 1996;117:1613-8.
39. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998;115:370-80.
40. 3 receptors. J Pharmacol Exp Ther 1999;288:93-7.